Skip to content

DR. OLIVIA VANDEPUT

Active
Private limited companyfounded 2013active for 13 yearsVeldonkstraat 17, 3120 Tremelo, BelgiumKBO/BCE: BE 0541.543.575
Summary

DR. OLIVIA VANDEPUT has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €303,822 and a net result of €47,324. Equity is growing by about 50% per year across the filed financial years. Its solvency ranks better than 60% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
2 sites
Size
≈ €190,000turnover 2025, estimated
Staff
≈ 0 FTE, estimated
Equity
€303,822
Profit
€47,324
Turnover estimated from the gross margin
Financial health
94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 31 days early2 of 4 deeds summarised
Why 94lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.99, cash €85,591Equity €303,822 (72.7% of total assets)Size: total assets €418,139Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 50% of its sector peers (NACE 86, micro)
Financial strength · tick = 2025
Strong
Solvency 98+9
equity 72.7% of total assets
Liquidity 76-7
short-term debt 10.0% · cash 20.5%
Profitability 83-2
return on assets 11.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,148 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025highest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.99, above the usual 1.5; short-term debt: 10% and cash: 20.5% of total assets), and 27.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 61% on solvency, 57% on liquidity and 31% on profitability.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 3.99, cash €85,591
NBB · annual accounts
lowers risk · Equity €303,822 (72.7% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €418,139
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2025
31 days early
2024
7 days early
2023
on the day
2022
29 days late
2021
22 days late
2020
6 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Algemene Vergadering - BoekjaarGeneral meeting
  3. Annual accounts filedfinancial year 2025 · micro…

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €47,324 8 years View
  • Positive: Filed on time since financial year 2023accounts within the deadline every year 4 years View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€418,139
Profit
€47,324
Solvency
72.7%
Total assets▲ 4.8%
Net result
20192025
Go to Financials

Timeline

Events
17
Since
2016
  1. 24-10-2024Annual accounts filed
  2. 31-03-2024Highest result from 2019 to 2025
  3. 31-03-2024Equity above €200,000
Go to Timeline

Company details

Sites
2
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
23-10-2013
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
12
Who signs
Each director alone
Annual meeting
Third Wednesday of June at 20:00
Purpose
“De uitoefening van de geneeskunde,meer bepaald de discipline van huisarts door de…” (deed in Dutch)
Go to Articles of association

Key facts about DR. OLIVIA VANDEPUT

What is the company number of DR. OLIVIA VANDEPUT?
0541.543.575. In Belgium the VAT number is the company number with BE in front: BE 0541.543.575.
Where is DR. OLIVIA VANDEPUT based?
The registered office is at Veldonkstraat 17, 3120 Tremelo.Company details
What does DR. OLIVIA VANDEPUT do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. OLIVIA VANDEPUT?
Private limited company (BV).
When was DR. OLIVIA VANDEPUT founded?
On 23-10-2013.
Is DR. OLIVIA VANDEPUT still active?
Yes, DR. OLIVIA VANDEPUT is an active enterprise in the KBO register.
How many employees does DR. OLIVIA VANDEPUT have?
On average 1 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
What is the turnover of DR. OLIVIA VANDEPUT?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is DR. OLIVIA VANDEPUT profitable?
In financial year 2025, DR. OLIVIA VANDEPUT made a profit of €47,324.
Where can I find the annual accounts of DR. OLIVIA VANDEPUT?
DR. OLIVIA VANDEPUT filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.

Companies related to DR. OLIVIA VANDEPUT

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.